Recent news on Transdermal

Daytrana (methylphenidate transdermal system) Provides Significant ...  -  25 May 2007
DentalPlans.com,...(HealthNewsDigest.com) - SAN DIEGO – Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that DAYTRANA™ (methylphenidate transdermal system),

WayPoint Biomedical Signs-On With Top Convenience Store Wholesale ...  -  25 May 2007
MacReport (press release),Clinical studies show the simple and easy-to-use transdermal patch helps prevent hangover symptoms safely and effectively. The product also boasts drug-free

Despite Limitations, the Lure of Transdermal Skin Patches Remains ...  -  May 20, 2007
HULIQ,The Greystone survey of transdermal skin patch products, therapies and commercialization factors provides a comprehensive analysis of the risks and

Rotigotine transdermal system approved for Parkinson's disease in US  -  May 17, 2007
RxPG NEWS,Rotigotine, a member of the dopamine agonist class of drugs, is delivered continuously through the skin (transdermal) using a silicone-based patch that is

FDA Approves SCHWARZ PHARMA's Neupro(R) (Rotigotine Transdermal ...  -  May 11, 2007
Medical News Today (press release),SCHWARZ PHARMA announced today that the US Food and Drug Administration (FDA) has approved Neupro(R) (Rotigotine Transdermal System) for the treatment of

Transdermal patch for Parkinson’s approved by FDA Transdermal ...  -  May 10, 2007
ToTheCenter.com,Neupro is the first transdermal patch approved for the treatment of symptoms of Parkinson’s disease,� the FDA said in a statement.

Neupro Transdermal Parkinson's Patch Approved  -  May 10, 2007
MedPage Today,The agent called Neupro represents both the first transdermal patch for Parkinson's and the first US approval of any kind for the active ingredient,

Tested: Transdermal Ozone Therapy at the Dubai Herbal and ...  -  May 8, 2007
7DAYS,For the more squeamish among us, like me, there is the option of Transdermal Ozone Therapy, which doesn’t involve any needles, just a really hot sauna.

GlaxoSmithKline to Look at Using OBJ's Enhanced Transdermal ...  -  May 7, 2007
Azom.comOBJ's Dermaportation technology, and its new Enhanced Transdermal Polymer material, enhance transdermal (through the skin) drug delivery.

Phosphagenics To Commence Phase 1b Transdermal Insulin Clinical ...  -  May 4, 2007
Medical News Today (press release),...to demonstrate the efficacy and safety of the improved formulation of its transdermal insulin product, TPM-02/Insulin, containing long-acting insulin.

Identifying Perceptions and Trends for Pharmaceutical Drug ...  -  May 24, 2007
Earthtimes.orgWhile there are numerous types of drug delivery technologies, both traditional and novel-such as oral, injection, transdermal, intranasal and

Noven Announces 2007 Annual Meeting Results  -  May 18, 2007
Genetic Engineering News (press release),Noven Pharmaceuticals, Inc., headquartered in Miami, Florida, is a leading developer of advanced transdermal drug delivery technologies and prescription

Schwarz Parkinson's patch ploughs on  -  May 10, 2007
LabTechnologist.com,The company's Neupro transdermal patch, which delivers a continuous flow of anti-Parkinson's drug rotigotine over a 24 hour period, has been approved by the

Schwarz Pharma Moves Ahead With Parkinson’s Patch  -  May 10, 2007
Seeking Alpha,PK) today received FDA approval for Neupro, its transdermal patch for treatment of early-stage Parkinson’s disease. Neupro has been on the market in Europe

Successful Human Clinical Trial of Chrono Therapeutic's Drug ...  -  May 3, 2007
PR Newswire (press release),Trial Convincingly Proves Functionality in Humans of CTI's Programmable, Pulsatile, Passive Transdermal Drug Delivery Device - ChronoDose(TM) BASEL,

BioSante Pharmaceuticals to Present at Upcoming Conferences  -  May 16, 2007
PharmaLive.com (press release),These hormone therapy products are gel formulations for transdermal administration that deliver bio-identical estradiol and testosterone.

Leading Women’s Health Doc from HER Place Launches ‘Straight Truth ...  -  May 1, 2007
PR Web (press release),...“In the United States, the ESTHER study comes as a surprise to women and most doctors,� said Vliet, who prescribes gels, patches and other transdermal

DJ DGAP-Adhoc: Schwarz Pharma AG: FDA Approves SCHWARZ PHARMA's ...  -  May 9, 2007
VisAvis (Pressemitteilung),FDA Approves SCHWARZ PHARMA's Neupro (Rotigotine Transdermal System) for the Treatment of early-stage Parkinson's Disease in USA SCHWARZ PHARMA announced

Sontra Announces OTC Bulletin Board Quotation  -  May 8, 2007
PR-Inside.com (Pressemitteilung),The Company is using its technical competencies in transdermal drug formulation, delivery systems and biosensors to develop a new paradigm in transdermal

FDA approves skin patch designed to treat symptoms of early ...  -  May 11, 2007
News-Medical.net,The Food and Drug Administration (FDA) has announced the approval of Neupro (rotigotine transdermal system), a skin patch designed to treat symptoms of

Labtec’s Next Generation Pain Patch Successful in Clinical Studies  -  26 Apr 2007
PharmaLive.com (press release),Labtec's transdermal Sufentanil product is intended to provide extended chronic pain relief for several days. The patch is not only very small but at the

Statement of the Chief Executive Officer of UCB to the 2007 Annual ...  -  26 Apr 2007
PharmaLive.com (press release),The Parkinson's patch Neupro® (rotigotine transdermal system) is now launched in more than ten European countries (including Germany, UK, Spain,

Intrinsa launched for low sexual desire in females  -  26 Apr 2007
Healthcare Republic...in oophorectomised and hysterectomised women (SM1 n=562, SM2 n=533), aged 20 to 70 years with HSDD, on concomitant oestrogen (oral or transdermal).

US PSYCH: Depression Remission Rates Remain Low, But There's Hope  -  26 Apr 2007
Psychiatric Times,But the selegiline transdermal patch, FDA approved in February 2006 for treating depression, bypasses the gut to eliminate those problems, Dr. Jefferson

VIVUS Reports First Quarter 2007 Financial Results and Accomplishments  -  26 Apr 2007
Business Wire (press release),...an investigational metered dose transdermal estradiol spray for the treatment of menopause symptoms, to KV Pharmaceutical Company.

Agile Therapeutics to report on new generation of transdermal ...  -  Apr 24, 2007
News-Medical.net,Agile is an early stage Women's Healthcare company, whose low estrogen dose, seven-day transdermal contraceptive patch is currently in phase 2 clinical

Noven to Present at Deutsche Bank Annual Health Care Conference  -  Apr 25, 2007
PharmaLive.com (press release),Noven Pharmaceuticals, Inc., headquartered in Miami, Florida, is a leading developer of advanced transdermal drug delivery technologies and prescription

Noven to Present at Deutsche Bank Annual Health Care Conference  -  Apr 25, 2007
Genetic Engineering News (press release),Noven Pharmaceuticals, Inc., headquartered in Miami, Florida, is a leading developer of advanced transdermal drug delivery technologies and prescription

Noven to Present at Deutsche Bank Annual Health Care Conference  -  Apr 25, 2007
Business Wire (press release),Noven Pharmaceuticals, Inc., headquartered in Miami, Florida, is a leading developer of advanced transdermal drug delivery technologies and prescription

Lawyer: Poisoning An Accident  -  Apr 25, 2007
Hartford Courant,Chemists told police that "transdermal contact would have caused burning throughout the entire lip area of the infant ... and the pesticide would have

New technologies, needs will spur transdermal/transmucosal delivery  -  Apr 17, 2007
In-PharmaTechnologist.com,17/04/2007 - A combination of new drugs, new patient needs and new technologies is likely to fuel steady growth in the transdermal/transmucosal drug

As Transdermal Drug Delivery Gains Acceptance, Market Shoots to ...  -  Apr 16, 2007
Drug Newswire (press release),Consequently, transdermal and transmucosal delivery systems, with their ability to deliver substantial amounts of drugs over a long period of time,

Prescription drugs addictive too  -  Apr 24, 2007
LaSalle News Tribune,...“The oral medications and transdermal patches are much more potent today,� Rietgraf said. “Fentanyl is the active ingredient in transdermal patches,

Noven Announces First Quarter 2007 Earnings Release Date  -  Apr 23, 2007
PharmaLive.com (press release),Noven Pharmaceuticals, Inc., headquartered in Miami, Florida, is a leading developer of advanced transdermal drug delivery technologies and prescription

Frost & Sullivan Commends Altea Therapeutics for Extending the ...  -  Apr 5, 2007
Drug Newswire (press release),The PassPort System has dramatically extended the range of diseases that can be treated using transdermal patches. This novel technology has presented a

Frost & Sullivan Commends Altea Therapeutics for Extending ...  -  Apr 3, 2007
Newswire Today (press release),Frost & Sullivan has presented Atlanta-based Altea Therapeutics with the 2007 Frost & Sullivan Technology Innovation Award in the field of transdermal drug

Potential Of Exelon® Patch As Promising Treatment Approach For ...  -  Apr 24, 2007
Medical News Today (press release),Exelon Patch (rivastigmine transdermal patch) is designed to provide smooth, continuous delivery of the drug through the skin. This maintains steady drug

Are estrogen patches, gels safer than pills after menopause?  -  Apr 23, 2007
Boston Globe,They found that oral hormone users had four-times the risk of blood clots compared with non-hormone users and with those using transdermal preparations.

The Speed and Control of Drug Concentrations Provided By ...  -  Mar 30, 2007
Business Wire (press release),This report highlights the technologies and drugs currently available for transdermal, buccal and intranasal routes of administration as well as an analysis

SCHWARZ PHARMA Announces Publication Of Rotigotine Data For ...  -  Apr 20, 2007
Medical News Today (press release),SCHWARZ PHARMA announced today the publication of an article titled, "Advanced Parkinson Disease Treated with Rotigotine Transdermal System: PREFER Study,"

First Quarter Report 2007: Schwarz Pharma with Good Start  -  Apr 25, 2007
PharmaLive.com (press release),Neupro ® (rotigotine transdermal patch) for treating Parkinson’s disease was successfully launched on the German market in March of last year.

SCHWARZ PHARMA Announces Publication of Rotigotine Data for ...  -  Apr 16, 2007
Drug Newswire (press release),Phase III trial results for transdermal rotigotine published in Neurology demonstrated a statistically significant reduction in 'off' time in advanced

Antares Pharma Announces Positive Results from Application Site ...  -  Apr 19, 2007
PharmaLive.com (press release),ANTUROL(R) ATD(TM) transdermal gel is intended to treat symptoms of overactive bladder (OAB), a lower urinary tract disorder resulting in a symptom syndrome

SCHWARZ PHARMA Announces Publication of Rotigotine Data for ...  -  Apr 16, 2007
PR-Inside.com (Pressemitteilung),Rotigotine is a non-ergolinic dopamine receptor-agonist formulated as a transdermal delivery system, a patch, designed for once-a-day application.

SHIRE PLC - 1st Quarter Results  -  Apr 25, 2007
PR-Inside.com (Pressemitteilung),...(methylphenidate transdermal system) - ADHD * Shire is planning to make regulatory filings in Europe for DAYTRANA in H2 2007.

KV Pharmaceutical Company Acquires US Rights to EvaMist(TM) - A ...  -  Mar 30, 2007
PR Newswire (press release),EvaMist(TM) Is A Novel, Low-Dose Estrogen Transdermal Spray, Pending FDA Approval, Expanding Ther-Rx's Presence into One of the Largest Therapeutic

KV Pharmaceutical Company Acquires US Rights to EvaMist(TM) - A ...  -  Apr 3, 2007
Drug Newswire (press release),EvaMist(TM), which has completed Phase III clinical trials, is a patented estradiol transdermal spray that offers a novel approach to the treatment of

Sontra Medical Reports Fourth Quarter and Fiscal Year 2006 Results ...  -  Apr 3, 2007
Drug Newswire (press release),The Company is using its technical competencies in transdermal drug formulation, delivery systems and biosensors to develop a new paradigm in transdermal

BioSante Pharmaceuticals Announces Issuance of New Patent Covering ...  -  Apr 10, 2007
Genetic Engineering News (press release),These hormone therapy products are gel formulations for transdermal administration that deliver bio-identical estradiol and testosterone.

arGentis Appoints Scientific Advisory Board  -  Apr 2, 2007
PharmaLive.com (press release),...arGentis is currently advancing two transdermal therapies for the treatment of dry eye syndrome (DES) into the clinical development.

Dermatrends Announces License Agreement With MINRAD International  -  Apr 5, 2007
Drug Newswire (press release),Dermatrends has received an up-front license fee for its proprietary transdermal delivery technology. MINRAD and Dermatrends will work together to jointly

Antares Pharma Announces Issuance of New Broad Patent Covering ...  -  Apr 11, 2007
American Digital Networks (press release),Antares' current technology platforms include its ATD(TM) Advanced Transdermal Delivery system, and its related TecTix(TM) system for topical and

Antares Pharma Announces Issuance of New Broad Patent Covering ...  -  Apr 11, 2007
Business Wire (press release),Antares’ current technology platforms include its ATD™ Advanced Transdermal Delivery system, and its related TecTix™ system for topical and transmucosal

Mylan Labs lifts 2007 earnings forecast  -  Apr 10, 2007
MarketWatchMylan's fentanyl transdermal patch, used to treat pain, is a generic version of the Duragesic patch, which is made by Johnson & Johnson's (JNJ :

Dermatrends Announces License Agreement With MINRAD International  -  Apr 3, 2007
PR-Inside.com (Pressemitteilung),...has received an up-front license fee for its proprietary transdermal delivery technology. MINRAD and Dermatrends will work together to jointly develop the

Dermatrends Announces License Agreement With MINRAD International  -  Apr 3, 2007
PR Newswire (press release),The company is dedicated to the development of proprietary transdermal and other drug delivery technologies, and it has demonstrated an enabling platform

Mylan raises earnings guidance  -  Apr 11, 2007
Bizjournals.com,...fiscal 2007 earnings to be higher than its forecast because of strong sales of generic drugs, such as fentanyl, the company's transdermal pain patch.

Improving Outcomes In Premature Births: Nitroglycerin Shows ...  -  Apr 1, 2007
Medical News Today (press release),The editorial is "Transdermal nitroglycerin for preterm labor" by Jay D. Iams, MD. Both appear in the American Journal of Obstetrics & Gynecology,

Antares Pharma Reveals Issuance Of New Broad Patent Covering ...  -  Apr 11, 2007
Trading Markets,...(RTTNews) - Antares Pharma, Inc. (AIS | charts | news | PowerRating) said that a new broad patent has been issued covering its ATD or Advanced Transdermal

KV to pay $150M for menopause drug rights  -  Mar 30, 2007
St. Louis Business Journal,EvaMist is a new estrogen transdermal spray that delivers estradiol for the treatment of vasomotor symptoms, such as hot flashes, associated with menopause.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional